<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9607835</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20545</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27457813</article-id>
<article-id pub-id-type="pmc">6186433</article-id>
<article-id pub-id-type="doi">10.1038/mp.2016.98</article-id>
<article-id pub-id-type="manuscript">NIHMS989728</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Functional Analysis of Rare Variants Found in Schizophrenia Implicates a Critical Role for GIT1-PAK3 Signaling in Neuroplasticity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Kim</surname>
<given-names>Myung Jong</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">~</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Biag</surname>
<given-names>Jonathan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">#</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Fass</surname>
<given-names>Daniel M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lewis</surname>
<given-names>Michael C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Qiangge</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fleishman</surname>
<given-names>Morgan</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gangwar</surname>
<given-names>Shanti Pal</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Machius</surname>
<given-names>Mischa</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fromer</surname>
<given-names>Menachem</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Purcell</surname>
<given-names>Shaun M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McCarroll</surname>
<given-names>Steven A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rudenko</surname>
<given-names>Gabby</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Premont</surname>
<given-names>Richard T.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scolnick</surname>
<given-names>Edward M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haggarty</surname>
<given-names>Stephen J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA</aff>
<aff id="A2"><label>2</label>Chemical Neurobiology Laboratory, Departments of Neurology &amp; Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA</aff>
<aff id="A3"><label>3</label>Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA</aff>
<aff id="A4"><label>4</label>Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA</aff>
<aff id="A5"><label>5</label>Molecular Neurogenetics Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA</aff>
<aff id="A6"><label>6</label>McGovern Institute for Brain Research, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA</aff>
<aff id="A7"><label>7</label>Department of Pharmacology and Toxicology, Sealy Center for Structural Biology &amp; Biophysics, University of Texas Medical Branch, 301 University Boulevard, Basic Sciences Building, Galveston Texas 77555</aff>
<aff id="A8"><label>8</label>Division of Psychiatric Genomics, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA</aff>
<aff id="A9"><label>9</label>Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.</aff>
<author-notes>
<fn fn-type="present-address" id="FN1">
<label>~</label>
<p id="P1">Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA;</p>
</fn>
<fn fn-type="present-address" id="FN2">
<label>#</label>
<p id="P2">Novartis Pharmaceuticals, Cambridge, MA, USA</p>
</fn>
<fn fn-type="con" id="FN3">
<p id="P4">Author Contributions</p>
<p id="P5">M.J.K, J.B., M.L., Q.Z., E.M.S., S.J.H. conceived and designed the experiments. M.J.K, J.B., M.L., D.M.F., S.J.H. performed the experiments and/or analyzed data. R.P. assisted with data interpretation and edited the manuscript. M.F., S.P., S.A.M., E.M.S., S.J.H. assisted with analysis of human genetic data. S.P.G., M.M. and G.R. performed homology model analysis. M.J.K, J.B., M.L., D.M.F., G.R., E.M.S., S.J.H. wrote and edited the manuscript. All authors discussed the results and implications and commented on the final version of the manuscript.</p>
</fn>
<corresp id="CR1"><bold>Correspondence:</bold> Dr. Stephen J. Haggarty (<email>shaggarty@mgh.harvard.edu</email>)</corresp>
<fn fn-type="COI-statement" id="FN4">
<p id="P45">Conflict of Interest</p>
<p id="P46">The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>14</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>22</volume>
<issue>3</issue>
<fpage>417</fpage>
<lpage>429</lpage>
<!--elocation-id from pubmed: 10.1038/mp.2016.98-->
<abstract id="ABS1">
<p id="P6">While the pathogenesis of schizophrenia (SCZ) is proposed to involve alterations of neural circuits via synaptic dysfunction, the underlying molecular mechanisms remain poorly understood. Recent exome sequencing studies of SCZ have uncovered numerous single nucleotide variants (SNVs); however, the majority of these SNVs have unknown functional consequences, leaving their disease relevance uncertain. Filling this knowledge gap requires systematic application of quantitative and scalable assays to assess known and novel biological functions of genes. Here we demonstrate loss-of-function effects of multiple rare coding SNVs found in SCZ subjects in the <italic>GIT1</italic> (G protein-coupled receptor kinase interacting ArfGAP 1) gene using functional cell-based assays involving co-expression of GIT1 and PAK3 (p21 protein (Cdc42/Rac)-activated kinase 3). Most notably, a GIT1-R283W variant reported in four independent SCZ cases was defective in activating PAK3 as well as MAPK (Mitogen-activated protein kinase). Similar functional deficits were found for a <italic>de novo</italic> SCZ variant GIT1-S601N. Additional assays revealed deficits in GIT1-R283Wâ€™s capacity to stimulate PAK phosphorylation in cultured hippocampal neurons. Also, GIT1-R283W showed deficits in the induction of GAD1 (Glutamate decarboxylase 1) protein expression. Extending these functional assays to ten additional rare GIT1 variants revealed the existence of an allelic series with the majority of the SCZ case variants exhibiting loss-of-function towards MAPK activation in a manner correlated with loss of PAK3 activation. Taken together, we propose that rare variants in GIT1, along with other genetic and environmental factors, cause dysregulation of PAK3 leading to synaptic deficits in SCZ.</p>
</abstract>
<kwd-group>
<kwd>schizophrenia</kwd>
<kwd>synapse</kwd>
<kwd>exome</kwd>
<kwd>GIT1</kwd>
<kwd>PAK3</kwd>
<kwd>GAD1</kwd>
<kwd>NMDA receptor</kwd>
<kwd>GRIN2A</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>